Show simple item record

dc.contributor.authorMatas Méndez, Pablo
dc.contributor.authorFuentes Corripio, Isabel 
dc.contributor.authorMontoya Matute, Ana
dc.contributor.authorBailo-Barroso, Begoña 
dc.contributor.authorGrande Gómez, Rebeca
dc.contributor.authorApruzzese Rubio, Ariadna
dc.contributor.authorPonce Gordo, Francisco
dc.contributor.authorMateo Barrientos, Marta
dc.date.accessioned2023-08-25T07:01:50Z
dc.date.available2023-08-25T07:01:50Z
dc.date.issued2023-08-01
dc.identifier.citationAnimals (Basel). 2023 Aug 1;13(15):2488.es_ES
dc.identifier.issn2076-2615es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16339
dc.description.abstractThe wildcat (Felis silvestris) and the Iberian lynx (Lynx pardinus) are important species in Spain, considered as near-threatened and endangered, respectively. Both can be infected by Toxoplasma gondii, a parasite that can cause morbidity and mortality in transplacentally-infected or immunocompromised mammals. The data on the prevalence of this parasite in wild populations of these species in Spain are outdated. The objective of this study was to update information and evaluate the role of these felines in parasite epidemiology and the potential impact of the parasite on their conservation. Blood and fecal samples were collected from captured animals, as well as the tongue, diaphragm, and spleen, from animals killed in road accidents in central Spain. An indirect fluorescent antibody test (IFAT) was used to detect parasite antibodies in serum, microscopy and molecular analysis were used to detect oocysts in feces, and molecular analysis was used to determine the existence of tissue cysts. Seroprevalence was 85% in wildcats and 45% in lynx, and parasite DNA was detected in the feces of one wildcat and in tissue samples from 10 wildcats and 11 Iberian lynxes. These results highlight the epidemiological importance and high risk of T. gondii infection in animals and humans in the studied areas. Considering feline susceptibility to infection, monitoring programs are needed to assess the health status of wild felines.es_ES
dc.description.sponsorshipThis research was partially funded by Alfonso X el Sabio Foundation, project number 1.010.119 and Health Research Fund, Instituto de Salud Carlos III, Ministry of Science and Innovation, project FIS AESI PI21CIII/00031.es_ES
dc.language.isoenges_ES
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectEuropean wildcates_ES
dc.subjectFelis silvestrises_ES
dc.subjectIberian lynxes_ES
dc.subjectLynx pardinuses_ES
dc.subjectToxoplasma gondiies_ES
dc.subjectPrevalencees_ES
dc.subjectEpidemiologyes_ES
dc.subjectImmunofluorescence antibodies testes_ES
dc.subjectPCRes_ES
dc.subjectSpaines_ES
dc.titlePrevalence of Toxoplasma gondii in Endangered Wild Felines (Felis silvestris and Lynx pardinus) in Spaines_ES
dc.typeresearch articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID37570297es_ES
dc.format.volume13es_ES
dc.format.number15es_ES
dc.format.page2488es_ES
dc.identifier.doi10.3390/ani13152488es_ES
dc.contributor.funderFundación Universidad Alfonso X el Sabio es_ES
dc.contributor.funderInstituto de Salud Carlos III es_ES
dc.contributor.funderAgencia Estatal de Investigación (España) es_ES
dc.contributor.funderMinisterio de Ciencia e Innovación (España) es_ES
dc.description.peerreviewedes_ES
dc.relation.publisherversionhttps://doi.org/10.3390/ani13152488es_ES
dc.identifier.journalAnimals : an open access journal from MDPIes_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III///PI21-ISCIII Modalidad Proyectos de Investigacion en Salud Intramurales. (2021)/PI21CIII/00031es_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This item is licensed under a: Atribución 4.0 Internacional